Researchers believe they have developed the first dedicated blood test to diagnose chronic fatigue syndrome (CFS), also known as myalgic encephalomyelitis (ME), which has the potential to be a ...

The U.S. FDA recently approved a new blood test to diagnose Alzheimer’s disease. The test, called Lumipulse, measures two proteins in plasma: pTau217 and ß-Amyloid 1-42. These proteins clump together ...

The complete blood count routine test provides a snapshot of your body's blood production and immunity. The test measures a variety of components in your blood, including red blood cells, white blood ...

People who develop rheumatoid arthritis experience changes to their immune systems long before their joints become swollen and painful, suggesting that early treatment might stop or limit damage, a ...

Cancer screening is at a turning point. For decades, most tests focused on one form of the disease — like mammograms for breast cancer or colonoscopies for colorectal cancer — but new advances have ...

For decades, patients with myalgic encephalomyelitis or chronic fatigue syndrome (ME/CFS) have faced a diagnostic dilemma. They have experienced or lived with debilitating fatigue, cognitive ...

PFAS are harmful ‘forever chemicals’ that have been linked to cancer and other serious health risks. This summer, the Danish Ministry of Environment and Gender Equality, together with the European ...

Oura launches blood test through Health Panels. The feature tests 50 biomarkers. Blood testing through wearable tech is the trend du jour. Tech companies want your blood now. That's the latest trend ...

(CNN) — The US Food and Drug Administration has given clearance to another blood test to help assess Alzheimer’s disease and other causes of cognitive decline, providing a broader understanding of ...

Breast Cancer Foundation NZ says the video sparked vital awareness and action. Video / Tiktok / @piafromnzblood “Have you eaten and had plenty to drink today?” You expect that question from the New ...

Needle-free blood tests like TAP and Tasso aim to help needle-phobic patients. They face hurdles regarding accuracy.

Scientists say they've developed a world-first blood test for chronic fatigue syndrome—but the claim has triggered an immediate backlash from fellow researchers, who branded it 'another false dawn'.